Diseases such as diabetes, cancer, multiple sclerosis and Alzheimer’s pose a tremendous challenge to modern medicine. Societies are ageing around the world, yet today's elders wish to remain active and healthy, and live useful lives for as long as possible.
Nanomedicine, the application of nanotechnology to human healthcare, offers numerous potential pathways to improving medical diagnosis and therapy and even to regenerate tissues and organs. It can provide personalised yet more affordable healthcare while at the same time offering an improved quality of life for everyone. Nanomedicine is also a strategic issue for the competitive position of the healthcare industry in Europe.
From 2007 to 2010, during the first four Calls of EU Framework Programme 7, the NMP Progamme invested about 265 Million Euros in nanomedicine related research such as targeted nanopharmaceuticals, nanodiagnostics, biomaterials for implants and regenerative medicine and the development of intelligent prostheses.
The European Technology Platform for Nanomedicine is an important industry-led forum that provides inputs for the research priorities to be addressed and gives advice on innovation related policy for the nanomedicine field.